Bristol's Merger With Celgene Is Already Paying Dividends: CEO
Bristol-Myers Squibb Co., fresh off completing one of the largest drug-industry mergers ever, is counting on the acquisition to pay off quickly with new products and ease Wall Street concerns...
Related Articles
- Proxy Voting Adds Some Spice to Plain-Vanilla Index Investing also published in morningstar.com
- Seeing the Risks, a Firm Transitions to ESG also published in morningstar.com
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Nokia Board Has Discussed Pursuit of Alcatel also mentions acquisition
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
Login to comment.